Professor Kenneth Oye speaks with WBUR’s Sacha Pfeiffer about his recent research that details a new way to alter the genomes of organisms and the need for a public discussion about the potential implications and benefits of this new technology.
Wall Street Journal reporter Ed Silverman interviews Professor Andrew Lo about his proposal that a public-private partnership could solve funding issues for drugs research and development. “Right now, the risk of failure [in developing an Alzheimer’s treatment] is far too high for any single pharmaceutical company to take on,” Lo explains.
Ph.D. candidate Josephine Wolff writes for Slate about the potential for allowing offensive computer security measures in order to protect networks. Wolff argues that the risks of endorsing these measures outweigh the benefits.
“Based on the current rates of success in creating new drugs for Alzheimer's disease, it could take 260 years until the next one is approved,” writes The Boston Globe’s Carolyn Johnson on the rationale for why Professor Andrew Lo is proposing a new, portfolio-based approach to Alzheimer's research.
Wall Street Journal reporter Irving Wladawsky-Berger examines Prof. David Autor’s research on income inequality. “Mr. Autor estimates that the difference in the yearly earnings between a college-educated two-income family and a high school-educated two-income family has risen by $28,000 between 1979 and 2012,” he writes.